Cohance Lifesciences Ltd.

BSE: 543064 | NSE: COHANCE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE03QK01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Cohance Lifesc Cohance Lifesciences Ltd. | BSE 753.20 -25.50 (-3.27%) | NSE 753.40 -25.55 (-3.28%) | Trade | Add

BSE Live

Oct 31, 16:01

753.20 -25.50 (-3.27%)

Volume

AVERAGE VOLUME

5-Day

17,800

10-Day

17,817

30-Day

23,635

53,652

NSE Live

Oct 31, 15:59

753.40 -25.55 (-3.28%)

Volume

AVERAGE VOLUME

5-Day

249,599

10-Day

282,567

30-Day

675,950

1,868,958

Financials

Print/Copy to Excel : Go

Cash Flow of Cohance Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	343.92	405.67	559.73	667.59	467.67
Net CashFlow From Operating Activities	288.16	358.48	450.91	330.00	383.44
Net Cash Used In Investing Activities	-255.30	-362.25	-194.84	-136.21	-311.40
Net Cash Used From Financing Activities	3.32	-13.80	-235.83	-156.41	-76.55
Foreign Exchange Gains / Losses	1.99	0.00	0.00	0.00	0.00
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	38.17	-17.57	20.24	37.38	-4.51
Cash And Cash Equivalents Begin of Year	47.23	64.80	44.56	7.18	11.70
Cash And Cash Equivalents End Of Year	85.40	47.23	64.80	44.56	7.18